Efficacy and Safety of Tislelizumab and Nab-paclitaxel Combined With Low-dose Radiotherapy in Patients With Stage IVb Esophageal Squamous Cell Carcinoma
Clinical trial NCT05547828 · UNKNOWN
Trial details
- NCT number
- NCT05547828
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical College
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-20
- Primary completion
- 2024-12-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.